Sandra A. Gardiner - 20 Mar 2025 Form 4 Insider Report for Adagio Medical Holdings, Inc. (ADGM)

Reporting relationship: Director
Issuer ticker: ADGM
Reported as of: 20 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Mar 2025, 18:59:40 UTC
Prior SEC filing: 01 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ John Dahldorf, Attorney-in-Fact

Key filing fact

Sandra A. Gardiner filed Form 4 for Adagio Medical Holdings, Inc. (ADGM) on 21 Mar 2025.

Key facts

This page summarizes Sandra A. Gardiner's Form 4 filing for Adagio Medical Holdings, Inc. (ADGM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Mar 2025, 18:59.

Change

Previous filing in this sequence was filed on 01 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ADGM transaction Derivative

Non-qualified stock option (right to buy)

Award

Transaction value: $0
Shares: +90,000
Change %
Price: $0.000000
Shares after: 90,000
Date: 20 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.8650
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024.